IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

被引:402
作者
Hainaut, P
Hernandez, T
Robinson, A
Rodriguez-Tome, P
Flores, T
Hollstein, M
Harris, CC
Montesano, R
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] European Bioinformat Inst, EMBL, Outstn, Cambridge, England
[3] German Canc Res Ctr, D-69120 Heidelberg, Germany
[4] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
基金
英国惠康基金;
关键词
D O I
10.1093/nar/26.1.205
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since 1989 about 570 different p53 mutations have been identified in more than 8000 human cancers. A database of these mutations was initiated by M. Hollstein and C. C. Harris in 1990. This database originally consisted of a list of somatic point mutations in the p53 gene of human tumors and cell lines, compiled from the published literature and made available in a standard electronic form, The database is maintained at the International Agency for Research on Cancer (IARC) and updated versions are released twice a year (January and July). The current version (July 1997) contains records on 6800 published mutations and will surpass the 8000 mark in the January 1998 release, The database now contains information on somatic and germline mutations in a new format to facilitate data retrieval, In addition, new tools are constructed to improve data analysis, such as a Mutation Viewer Java applet developed at the European Bioinformatics Institute (EBI) to visualise the location and impact of mutations on p53 protein structure, The database is available in different electronic formats at IARC (http://www.iarc.fr/p53/homepage.htm) or from the EBI server (http://www.ebi.ac.uk). The IARC p53 website also provides reports on database analysis and links with other p53 sites as well as with related databases, In this report, we describe the criteria for inclusion of data, the revised format and the new visualisation tools. We also briefly discuss the relevance of p53 mutations to clinical and biological questions.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 32 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   p53 gene mutation: Software and database [J].
Beroud, C ;
Verdier, F ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1996, 24 (01) :147-150
[3]   p53 gene mutation:: software and database [J].
Béroud, C ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :200-204
[4]   ASSOCIATION BETWEEN CIGARETTE-SMOKING AND MUTATION OF THE P53 GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BRENNAN, JA ;
BOYLE, JO ;
KOCH, WM ;
GOODMAN, SN ;
HRUBAN, RH ;
EBY, YJ ;
COUCH, MJ ;
FORASTIERE, AA ;
SIDRANSKY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :712-717
[5]   Databases and software for the analysis of mutations in the human p53 gene, human hprt gene and both the lacI and lacZ gene in transgenic rodents [J].
Cariello, NF ;
Douglas, GR ;
Gorelick, NJ ;
Hart, DW ;
Wilson, JD ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :198-199
[6]   Databases and software for the analysis of mutations in the human p53 gene, the human hprt gene and the lacZ gene in transgenic rodents [J].
Cariello, NF ;
Douglas, GR ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1996, 24 (01) :119-120
[7]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[8]   Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 [J].
Denissenko, MF ;
Pao, A ;
Tang, MS ;
Pfeifer, GP .
SCIENCE, 1996, 274 (5286) :430-432
[9]   Mutational spectra: From model systems to cancer-related genes [J].
Dogliotti, E .
CARCINOGENESIS, 1996, 17 (10) :2113-2118
[10]  
ETZOLD T, 1993, COMPUT APPL BIOSCI, V9, P49